Literature DB >> 19940993

[Glaucoma drainage devices].

H Thieme1.   

Abstract

Glaucoma drainage devices (GDDs) have a fixed place in the treatment of complicated refractory glaucoma. By implantation of an episcleral GDD, a permanent open sclerostomy is formed, through which a silicone tube is placed into the anterior chamber (or pars plana). Thus, aqueous humor is drained out of the eye under the Tenon and conjunctiva, leading the fluid to a base plate made from silicone or polypropylene. Placed near the equator of the eye, this base plate leads to the formation of a cyst that renders resistance to fluid transport, ultimately leading to a final drop in intraocular pressure. GDDs have been mainly used in complicated glaucoma cases that had previous unsatisfactory results from conventional glaucoma surgery. Recent studies suggest that the implants can also be used satisfactorily in early stages of glaucoma. Other devices are positioned and fixed in the chamber angle. Here they either drain aqueous humor into the Schlemm's canal or into the subconjunctival or subchoroidal space. This article gives an overview of the current principles, indications, methods, and possible complications of implantation.

Entities:  

Mesh:

Year:  2009        PMID: 19940993     DOI: 10.1007/s00347-009-2090-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  40 in total

1.  Histopathologic and immunohistochemical analysis of the filtration bleb after unsuccessful glaucoma seton implantation.

Authors:  L Classen; T Kivelä; A Tarkkanen
Journal:  Am J Ophthalmol       Date:  1996-08       Impact factor: 5.258

2.  Comparison of double-plate Molteno and Ahmed glaucoma valve in patients with advanced uncontrolled glaucoma.

Authors:  Ramesh S Ayyala; David Zurakowski; R Monshizadeh; Chian-Huey Hong; David Richards; William E Layden; B T Hutchinson; A R Bellows
Journal:  Ophthalmic Surg Lasers       Date:  2002 Mar-Apr

3.  The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study.

Authors:  L Cantor; J Burgoyne; S Sanders; V Bhavnani; J Hoop; E Brizendine
Journal:  J Glaucoma       Date:  1998-08       Impact factor: 2.503

4.  The effect of adjunctive Mitomycin C in Ahmed glaucoma valve implantation.

Authors:  E Kurnaz; A Kubaloglu; Y Yilmaz; A Koytak; Y Ozertürk
Journal:  Eur J Ophthalmol       Date:  2005 Jan-Feb       Impact factor: 2.597

5.  Coexistent primary open-angle glaucoma and cataract: interim analysis of a trabecular micro-bypass stent and concurrent cataract surgery.

Authors:  Detlev Spiegel; Wolfgang Wetzel; Thomas Neuhann; Jorg Stuermer; Helmut Hoeh; Julian Garcia-Feijoo; José Maria Martinez-De-La-Casa; Julian Garcia-Sanchez
Journal:  Eur J Ophthalmol       Date:  2009 May-Jun       Impact factor: 2.597

6.  Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial.

Authors:  Vital P Costa; Augusto Azuara-Blanco; Peter A Netland; Mark R Lesk; Enyr S Arcieri
Journal:  Ophthalmology       Date:  2004-06       Impact factor: 12.079

7.  A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma.

Authors:  R S Ayyala; D Zurakowski; J A Smith; R Monshizadeh; P A Netland; D W Richards; W E Layden
Journal:  Ophthalmology       Date:  1998-10       Impact factor: 12.079

8.  Ahmed glaucoma valve implantation in uveitic glaucoma versus open-angle glaucoma patients.

Authors:  Rony Rachmiel; Graham E Trope; Yvonne M Buys; John G Flanagan; Mary L Chipman
Journal:  Can J Ophthalmol       Date:  2008-08       Impact factor: 1.882

9.  Evaluation of the hypertensive phase after insertion of the Ahmed Glaucoma Valve.

Authors:  Kouros Nouri-Mahdavi; Joseph Caprioli
Journal:  Am J Ophthalmol       Date:  2003-12       Impact factor: 5.258

10.  Glaucoma drainage implants in the treatment of refractory glaucoma in pediatric patients.

Authors:  R Autrata; I Helmanova; H Oslejskova; P Vondracek; J Rehurek
Journal:  Eur J Ophthalmol       Date:  2007 Nov-Dec       Impact factor: 2.597

View more
  1 in total

1.  [Clinical results of encapsulated bleb removal after Ahmed glaucoma valve implants].

Authors:  J Rosbach; L Choritz; N Pfeiffer; H Thieme
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.